• Core One Labs completes acquisition of Akome Biotech expresspharma
    May 07, 2021
    Akome’s proprietary cGMP drug formulations comprising psychedelic compounds and plant bioactives distinguish its approach on the psychedelic treatment of neurological disorders from other companies.
PharmaSources Customer Service